The role of IL-17 in acute kidney injury

Acute kidney injury (AKI) is a common clinical kidney disease with a high mortality rate. AKI is caused by a variety of factors, including sepsis, ischemia, and nephrotoxic drugs, and can progress to chronic kidney disease and end-stage renal disease. Numerous studies have suggested that cytokines can be used as therapeutic targets for AKI. IL-17 is a pro-inflammatory cytokine that not only participates in the host defense and the development of autoimmune diseases but also is linked to AKI due to a variety of factors. This review will give an overview of the structure, signaling pathways, and biological functions of IL-17, as well as its role in AKI, to show that IL-17 is a potential target for the prevention and treatment of AKI.

Automated summary

Acute kidney injury (AKI) is a common kidney disease with a high mortality rate. It can be caused by various factors and has the potential to progress to chronic kidney disease. IL-17, a pro-inflammatory cytokine, is linked to AKI and can be targeted for its prevention and treatment. This review provides an overview of IL-17's structure, signaling pathways, biological functions, and its role in AKI.